SCHEMBL27012091

SCHEMBL27012091

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccc(-c6ccccc6)c6ccccc56)cc4)c4cccc(-c5ccccc5-n5c6ccccc6c6ccccc65)c4)cc3)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPK14 Q16539 1/20 0.35
METAP2 P50579 1/20 0.33
ASH1L Q9NR48 3/20 0.32
HTR6 P50406 2/20 0.32
MCL1 Q07820 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
APP P05067 1/20 0.32
HSD17B10 Q99714 1/20 0.31
MGLL Q99685 1/20 0.31
HTR1A P08908 1/20 0.30
HTR2A P28223 1/20 0.30
HTR7 P34969 1/20 0.30
HTR5A P47898 1/20 0.30
TSPO P30536 1/20 0.30
BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24948202 0.99 KDM4E (0.35) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL24948168 0.97 ATM (0.34) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL27012040 0.95 MAPK14 (0.33) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL24948184 0.95 MCL1 (0.39) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL24948164 0.95 MCL1 (0.39) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL27012035 0.95 KDM4E (0.34) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL27012026 0.95 MAPK14 (0.32) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL27012092 0.95 KDM4E (0.34) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL20812997 0.95 KDM4E (0.36) KDM4EATML3MBTL1ALDH1A1MAPK14
SCHEMBL24902535 0.95 KDM4E (0.36) KDM4EATML3MBTL1ALDH1A1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-01-18 US disclosed
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 KDM4E 436/4885ATM 2358/4885L3MBTL1 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.